Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms.
about
European evidence based consensus on the diagnosis and management of Crohn's disease: special situationsMolecular evidence for two forms of Crohn diseaseCurrent trends in inflammatory bowel disease: the natural historyTNFSF15 is an ethnic-specific IBD geneEvidence-based clinical practice guidelines for Crohn's disease, integrated with formal consensus of experts in JapanEvaluation of inflammatory activity in Crohn's disease and ulcerative colitisGenotypes and phenotypes in Crohn's disease: do they help in clinical management?Factors associated with disease evolution in Greek patients with inflammatory bowel disease.Strategies for the prevention of postoperative recurrence of Crohn's disease.Defining quality indicators for best-practice management of inflammatory bowel disease in Canada.Postoperative recurrence of Crohn's disease: pathophysiology and prevention.Natural history of Crohn's disease following total colectomy and end ileostomy.How to do without steroids in inflammatory bowel disease.Resistance to activated protein C is a risk factor for fibrostenosis in Crohn's disease.Medical management of Crohn's disease.Natural course of Crohn's disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms.Factors influencing postoperative recurrence of Crohn's disease in childhoodDiagnostic misclassification reduces the ability to detect linkage in inflammatory bowel disease genetic studies.Surgical recurrence in Crohn's disease: Are we getting better?Review article: indication and type of surgery in Crohn's disease.Predicting, treating and preventing postoperative recurrence of Crohn's disease: the state of the field.A multivariate analysis of risk factors associated with recurrence following surgery for Crohn's disease.Anticipation in familial Crohn's disease.Postoperative outcome of Crohn's disease in 30 childrenMarker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics.Crohn's disease severity in familial and sporadic cases.Early development of stricturing or penetrating pattern in Crohn's disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype.Factors affecting recurrence after surgery for Crohn's disease.Crohn's is not a 6-week disease: lifelong management of mild to moderate Crohn's disease.Long-term Outcomes and Risk Factors for Reoperation After Surgical Treatment for Gastrointestinal Crohn Disease According to Anti-tumor Necrosis Factor-α Antibody Use: 35 Years of Experience at a Single Institute in Korea.Factors affecting outcomes in Crohn's disease over 15 years.Crohn's Disease Localization Displays Different Predisposing Genetic VariantsA rolling phenotype in Crohn's disease.European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosisRecurrence rates in Crohn's disease: predicting the future and predicting the past.The significance of fibrotic tight strictures of the ileum in Crohn's disease.Effectiveness of concomitant enteral nutrition therapy and infliximab for maintenance treatment of Crohn's disease in adults.Phenotype classification in IBD: Is there an impact on therapy?A meta-analysis comparing incidence of recurrence and indication for reoperation after surgery for perforating versus nonperforating Crohn's disease.Difference in recurrence patterns between anastomosis and strictureplasty after surgical treatment for crohn disease.
P2860
Q22242050-D0D955C7-8C79-4ED6-9D25-1B82359EF47CQ24564066-60AA807D-D6B1-46C1-891D-1083EA3FC313Q24629009-8051395E-59E8-4C01-A906-30587E6C19ADQ24644834-7E01D52F-7DDA-4F3B-9A4A-6987C383D6ADQ26829392-824D5015-896B-4AFC-8562-7C3FB14E03A0Q26996550-00470ACD-21DF-4822-BF25-E1747D759EEEQ30478821-4C08961A-5B57-49C9-9261-FF5851088EB1Q30820594-BB5EF814-9F2F-4A42-B0D0-BF51AFDF5338Q31122078-80D2FD33-10D0-4762-938E-4B435A56A282Q33725615-EFE05D1E-F608-4845-A741-3B580D8FC8BFQ33783117-6DED19D7-28C5-4167-8343-295A519AB209Q33785648-B0A6619D-C559-4480-BA13-76BE9230E163Q33853564-FA56F932-3169-4BA4-A74E-282A0B23594FQ34013076-41E1D532-C55D-48DC-871B-2FD52FD9508FQ34046139-9440129D-9D70-424E-B83C-D79B4777CF78Q34375104-355772CE-8F7C-4416-9195-66ADEE20AE1FQ34393882-B1CF8FA2-8BDC-48AD-ACCC-10733A486C38Q34439964-48C39AD8-C4EB-40D8-8837-BE29F844B6E3Q34478900-3E1463FB-6E42-41A8-9CE4-55CCFAECA935Q34669250-91FCD0A2-7EA1-40FA-9954-8FBD8D951A23Q34789021-CB43991F-42D3-47EA-BAF1-338C165959CFQ35147227-82925CD9-8A69-41D2-A418-BA5193F12AA0Q35349176-484B82D4-B101-4A90-B061-577D00BFD06AQ35353256-A8DD1E99-0D53-4B00-BAB8-1735D84C88E3Q35361496-59068660-CF6A-4179-8ABC-FED494C09A1FQ35565525-0CD6A531-54D9-4FF1-B352-05E204FB9062Q35595508-012DEFBC-A028-4842-AFB3-118A4807626CQ35851097-EDEF0870-292F-438F-8C50-73116B064322Q35913934-EA284FAE-A1C1-4067-88E8-3C4ADA2C59ECQ36043775-2202F453-BE44-4B4A-9B69-627D9DEDAEC4Q36073254-D3893B30-455B-4039-9F01-4F37D8E76F01Q36239381-0DBC6498-6718-4091-BB61-71725338C035Q36338563-7F2E2899-0D3E-4BB1-A880-9CB0D0BD9F5AQ36397893-954A1C80-8C61-4A56-9BB5-12D8DFAC149CQ36540021-945A0871-7ED1-470F-AE43-F809330D4F3FQ36647018-D2CC2CE3-189B-4539-8F3D-D3CCB0C172C9Q36865926-B65C1252-0510-4A67-B40A-B30CEF0AF5D3Q36925722-76879D09-8663-490C-8F65-82E857C36E20Q36953703-A8AE357D-6ECA-44E7-8DE8-0F185694F28BQ37044851-E546EB70-8F75-4400-8095-47EA3E1517F0
P2860
Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Perforating and non-perforatin ...... idence for two clinical forms.
@en
type
label
Perforating and non-perforatin ...... idence for two clinical forms.
@en
prefLabel
Perforating and non-perforatin ...... idence for two clinical forms.
@en
P2093
P2860
P356
P1433
P1476
Perforating and non-perforatin ...... idence for two clinical forms.
@en
P2093
Aufses AH Jr
Greenstein AJ
Janowitz HD
Springhorn J
P2860
P304
P356
10.1136/GUT.29.5.588
P407
P577
1988-05-01T00:00:00Z